Genelux GNLX
NASDAQ GNLX
$2.48 -0.04 (-1.59%)
At close: Sep 10, 2026 · 4:00 PM EDT

Genelux (GNLX) Profit After Tax (2022 - 2026)

Genelux (GNLX) posted Profit After Tax of -$8.9 million for Q1 2026, up 3.29% on a QoQ basis from -$9.2 million in Q4 2025, and down 18.8% year-over-year from -$11.0 million in Q1 2025.

Analysis

Genelux (GNLX) Profit After Tax (2022 - 2026) Analysis & Trends

Genelux has reported Profit After Tax for 5 years, with the latest figure at -$8.9 million in Q1 2026.

  • On a quarterly basis, Profit After Tax fell 18.8% year-over-year to -$8.9 million in Q1 2026; TTM through Mar 2026 was -$33.6 million, a 13.7% decrease from a year earlier, with the FY2025 full-year figure at -$32.2 million, down 7.8% from the prior year.
  • Profit After Tax was -$8.9 million for Q1 2026 at Genelux, up from -$9.2 million in the prior quarter.
  • The five-year high for Profit After Tax was $4.9 million in Q3 2022, with the low at -$10.4 million in Q1 2023.
  • Average Profit After Tax over 5 years is -$6.5 million, with a median of -$7.5 million recorded in 2025.
  • The sharpest annual moves came in 2023 and 2024: Profit After Tax tumbled 208.88% in 2023, then advanced 24.26% in 2024.
  • Over 5 years, Profit After Tax stood at -$3.5 million in 2022, then slumped by 93.62% to -$6.8 million in 2023, then sank by 32.64% to -$9.0 million in 2024, then slipped by 3.01% to -$9.2 million in 2025, then gained by 3.29% to -$8.9 million in 2026.
  • The last three Profit After Tax figures came in at -$8.9 million (Q1 2026), -$9.2 million (Q4 2025), and -$8.0 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 2.38 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -10.50 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.10 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.30 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 472.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -782.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 164.49 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 97.50 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -290.61 Mn
10 Genelux 108.17 Mn 108.17 Mn - -8.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.94 Mn
Dec 31, 2025 -9.25 Mn
Sep 30, 2025 -7.95 Mn
Jun 30, 2025 -7.46 Mn
Mar 31, 2025 -7.53 Mn
Dec 31, 2024 -8.98 Mn
Sep 30, 2024 -6.47 Mn
Jun 30, 2024 -6.58 Mn
Mar 31, 2024 -7.85 Mn
Dec 31, 2023 -6.77 Mn
Sep 30, 2023 -5.35 Mn
Jun 30, 2023 -5.82 Mn
Mar 31, 2023 -10.36 Mn
Dec 31, 2022 -3.50 Mn
Sep 30, 2022 4.91 Mn